Table 1. Demographic and baseline characteristics of patients with SARS-CoV-2 infection.
| All patients (N = 160) | Mild (n = 92) | Moderate (n = 19) | P value (Moderate vs Mild) | Severe (n = 49) | P value (severe vs Mild) | P value (Severe vs Moderate) | |
|---|---|---|---|---|---|---|---|
| Variables | |||||||
| Age (year) | 54 (38–64) | 51 (35–61) | 50 (38–66) | 0.52 | 58 (50–70) | 0.001* | 0.081 |
| Sex | - | - | - | 0.52 | - | 0.035* | 0.425 |
| Male | 82 (51%) | 41 (45%) | 10 (53%) | - | 31 (63%) | - | - |
| Female | 78 (49%) | 51 (55%) | 9 (47%) | - | 18 (37%) | - | - |
| Exposure history | |||||||
| Contact with suspected or confirmed COVID 19 cases | 68 (43%) | 51 (55%) | 7 (37%) | 0.155 | 10 (20%) | 0.001* | 0.273 |
| No clear contact history | 7 (4%) | 4 (4%) | 0 | - | 3 (6%) | - | - |
| History of recent travel outside DRC | 5 (3%) | 3 (3%) | 0 | - | 2 (4%) | - | - |
| Comorbidities | |||||||
| Any | 74 (46%) | 31 (33%) | 11 (58%) | 0.048* | 32 (65%) | 0.0003* | 0.572 |
| Hypertension | 55 (34%) | 24 (26%) | 10 (53%) | 0.023* | 21 (43%) | 0.043* | 0.471 |
| Diabetes | 31 (19%) | 14 (15%) | 5 (26%) | 0.244 | 12 (24%) | 0.178 | 0.877 |
| Obesity | 13 (8%) | 7 (8%) | 2 (11%) | - | 4 (8%) | - | - |
| Heart disease | 11 (7%) | 2 (2%) | 2 (11%) | - | 7 (14%) | - | - |
| Asthma / chronic pulmonary disease | 5 (3%) | 1(1%) | 1 (5%) | - | 3 (6%) | - | - |
| Time before seeking care (day) | 7 (5–10) | 5 (4–7) | 7 (4.5–8.5) | 0.817 | 7 (6.5–10) | 0.003 * | 0.074 |
| Therapeutic itinerary | - | - | - | 0.006* | <0.0001 | 0.589 | |
| Transferred from non-CTC hospitals | 42 (26%) | 11 (12%) | 8 (42%) | - | 23 (47%) | - | - |
| Attended Cl.Ng. from home | 118 (74%) | 81 (88%) | 11 (58%) | - | 26 (53%) | - | - |
| Within Cl.Ng. Coachtment area | 83 (52%) | 47 (51%) | 9 (47%) | 0.768 | 27 (55%) | 0.651 | 0.569 |
| Self-reporting Antimalarial treatment before hospitalization | 70 (44%) | 27 (29%) | 12 (63%) | 0.043* | 31 (64%) | 0.0003* | 0.576 |
Data are n (%) or median (IQR), Cl.Ng.: Clinique Ngaliema CTC: COVID-19 treatment center, COVID 19: Coronavirus disease 2019.